Google+ Facebook Twitter Twitter

Nanopore sequencing for rare genetic disorders

Using nanopore sequencing investigators can accurately detect specific genomic disorders in a fraction of the time it takes to conduct traditional and molecular cytogenetic testing.

This sequencing is a third-generation scalable technology that enables direct, real-time analysis of long DNA or RNA fragments.

Among a wide range of possible applications, it has proven effective in identifying copy number variants (CNVs). These are additional or missing copies of genetic material within chromosomes, and they underlie many neurological, psychiatric, and malformation disorders. Routinely, CNVs are investigated through cytogenomic techniques with significant limitations in terms of resolution and turnaround times.

Lead investigator Alberto Magi said: “Conventional cytogenetics and chromosomal microarray analysis are still the gold standard for the detection of large and small CNVs, respectively, and second-generation sequencing, developed for different genetic alterations, has been adapted to identify CNVs. But because they are slow, expensive and often inconclusive, patients are given sequential genetic tests until the underlying genetic cause is finally identified."

Image credit | Shutterstock

Related Articles

Genetic method for identifying hundreds of disease agents

A new paper compares the pathogen-detecting ability of a next-generation sequencing (NGS) system — the Respiratory Pathogen Infectious Diseases/Antimicrobial Resistance Panel (RPIP) — with a previously studied NGS system and standard of care (SOC) diagnostic methods for samples obtained with bronchoalveolar lavage.

“Gene editing via CRISPR/cas9 can lead to cell toxicity and genome instability”

CRISPR/Cas9 is a commonly used, very precise, gene editing technique often known as “genetic scissors”.

AI and ecg heart trace to predict diabetes

An artificial intelligence (AI) algorithm, derived from the features of individual heartbeats recorded on an ECG (electrocardiogram), can accurately predict diabetes and pre-diabetes, suggests preliminary research.

An electrophoresis case study

Madihah Abbas, Specialist Biochemistry Team Manager at Christie Pathology Partnership, looks at result interpretation, comparing gel and capillary zone electrophoresis.